Kankere-Ibrutinib Intermediates

  • 3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 330786-24-8

    3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine 330786-24-8

    Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Indasteri Pharmaceutical |Lithethefatsi tsa Antitumor |Ibrutinib Intermediates |3-(4-Phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |CAS: 330786-24-8 |C17H13N5O

    patlisisodintlha
  • 3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole 330792-70-6

    3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole 330792-70-6

    Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Indasteri Pharmaceutical |Lithethefatsi tsa Antitumor |Ibrutinib Intermediates |3-Amino-4-cyano-5-(4-phenoxyphenyl)pyrazole |CAS: 330792-70-6|Setšoantšo sa C16H12N4O

    patlisisodintlha
  • 1-Boc-3-hydroxypiperidine 85275-45-2

    1-Boc-3-hydroxypiperidine 85275-45-2

    Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Indasteri Pharmaceutical |Lithethefatsi tsa Antitumor |Ibrutinib Intermediates |1-Boc-3-hydroxypiperidine |CAS: 85275-45-2 |C10H19NO3

    patlisisodintlha
  • (S)-1-Boc-3-hydroxypiperidine 143900-44-1

    (S)-1-Boc-3-hydroxypiperidine 143900-44-1

    Litsebi tsa tlhahiso le phepelo ea biopharmaceutical |Lisebelisoa tse tala |Li-Reagents tsa Pharmaceutical Intermediates |Indasteri Pharmaceutical |Lithethefatsi tsa Antitumor |Ibrutinib Intermediates |(S) -1-Boc-3-hydroxypiperidine |CAS: 143900-44-1 |C10H19NO3

    patlisisodintlha